{
    "title": "Cipla asks India to revoke Novartis patents on respiratory drug",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-2814156/Cipla-asks-India-revoke-Novartis-patents-respiratory-drug.html",
    "date": "2014-10-30",
    "keywords": [
        "drug",
        "patent",
        "government",
        "cipla",
        "novartis",
        "india",
        "company",
        "october",
        "drugmaker",
        "copy",
        "marketcipla",
        "delhi",
        "official",
        "policy",
        "section",
        "year",
        "property",
        "gmt",
        "email",
        "zeba",
        "siddiquimumbai",
        "ltd",
        "thursday",
        "firm",
        "ag",
        "onbrez",
        "access",
        "medicine",
        "quantity",
        "switzerland",
        "shortage",
        "marketbig",
        "pharma",
        "price",
        "protection",
        "growth",
        "indias",
        "revenue",
        "need",
        "respiratory",
        "treatment",
        "fifth",
        "cost",
        "productcipla",
        "country",
        "statement",
        "request",
        "spokeswoman",
        "notice",
        "action",
        "battle",
        "department",
        "promotion",
        "power",
        "interest",
        "holder",
        "opportunity",
        "indicaterol",
        "disease",
        "copd",
        "diseasenovartis",
        "criticism",
        "supreme",
        "court",
        "cancer",
        "glivec",
        "copiesthe",
        "ustr",
        "approval",
        "plan",
        "thinktank",
        "minister",
        "nirmala",
        "sitharaman",
        "month",
        "reporting",
        "caroline",
        "copley",
        "editing",
        "sumeet",
        "greg",
        "mahlich"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}